A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

por Haisma, H. J., Boven, E., van Muijen, M., de Jong, J., van der Vijgh, W. J., Pinedo, H. M.
Publicado 1992

Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide

por van Muijen, M. E., van der Schoot, L. S., van den Reek, J. M. P. A., de Jong, E. M. G. J.
Publicado 2021

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

por Michielsens, C. A. J., van Muijen, M. E., Verhoef, L. M., van den Reek, J. M. P. A., de Jong, E. M. G. J
Publicado 2021